CAS 1010073-75-2

Formula: C22H22ClN7O2

InChI: InChI=1S/C22H22ClN7O2/c1-32-18-13-15(4-5-17(18)23)28-9-11-29(12-10-28)19(31)14-30-22-16(3-2-6-26-22)20(27-30)21-24-7-8-25-21/h2-8,13H,9-12,14H2,1H3,(H,24,25)

InChI key: ZIMLRKWQDLVPEK-UHFFFAOYSA-N

SMILES: COC1=C(C=CC(=C1)N2CCN(CC2)C(=O)CN3C4=C(C=CC=N4)C(=N3)C5=NC=CN5)Cl

1-[4-(4-Chloro-3-methoxyphenyl)-1-piperazinyl]-2-[3-(1H-imidazol-2-yl)-1H-pyrazolo[3,4-b]pyridin-1-yl]ethanone

CAS: 1010073-75-2

Formula: C₂₂H₂₂ClN₇O₂

Purity: 98%

Molecular weight: 451.9088

Ref: IN-DA01EOL2

CCX354

CAS: 1010073-75-2

CCX354

Formula: C₂₂H₂₂ClN₇O₂

Purity: ≥98%

Molecular weight: 451.91

Ref: 54-BUP08693

CCX354

Controlled Product

CAS: 1010073-75-2

CCX354 is a potent Chinese medicinal compound that acts as a kinase inhibitor. It has been shown to inhibit the cell cycle and induce apoptosis in human leukemia cells, making it a promising candidate for cancer treatment. CCX354 works by blocking the activity of specific proteins involved in tumor growth and survival, leading to decreased proliferation and increased cell death. This compound has also been found to be effective against various cancer cell lines, making it a versatile tool for cancer research. With its potential as a powerful anti-cancer agent, CCX354 represents an exciting new avenue for the development of novel cancer therapies.

Formula: C₂₂H₂₂ClN₇O₂

Purity: Min. 95%

Molecular weight: 451.9 g/mol

Ref: 3D-KQB07375

CCX354

CAS: 1010073-75-2

CCX354 (CCR1 antagonist 1) is a potent small molecule CCR1 antagonist with anti-inflammatory activity for the treatment of rheumatoid arthritis.

Formula: C₂₂H₂₂ClN₇O₂

Purity: 99.43% - 99.44%

Color and Shape: Solid

Molecular weight: 451.909

Ref: TM-T15253